CCL vs FGEN · P/E 15, rev $26.62B vs rev $29.6M
Carnival Corporation (CCL) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported CCL revenue for 2025-11-30 was $26.62B. Net income was $2.76B. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the CCL and FGEN stock pages for the full models.
Not investment advice.